Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction.
Sueta D, Suyama K, Sueta A, Tabata N, Yamashita T, Tomiguchi M, Takeshita T, Yamamoto-Ibusuki M, Yamamoto E, Izumiya Y, Kaikita K, Yamamoto Y, Hokimoto S, Iwase H, Tsujita K.
Sueta D, et al.
Atherosclerosis. 2017 May;260:116-120. doi: 10.1016/j.atherosclerosis.2017.03.039. Epub 2017 Mar 30.
Atherosclerosis. 2017.
PMID: 28390289
Clinical Trial.